<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Russian Journal of Infection and Immunity</journal-id><journal-title-group><journal-title xml:lang="en">Russian Journal of Infection and Immunity</journal-title><trans-title-group xml:lang="ru"><trans-title>Инфекция и иммунитет</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2220-7619</issn><issn publication-format="electronic">2313-7398</issn><publisher><publisher-name xml:lang="en">SPb RAACI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">635</article-id><article-id pub-id-type="doi">10.15789/2220-7619-2019-2-253-261</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>REVIEWS</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>ОБЗОРЫ</subject></subj-group><subj-group subj-group-type="article-type"><subject>Unknown</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Mechanisms of interacting <italic>Helicobacter pylori</italic> with gastric mucosal epithelium. II. A reaction of gastric epithelium on <italic>Helicobacter pylori</italic> colonization and persistence</article-title><trans-title-group xml:lang="ru"><trans-title>Механизмы взаимодействия <italic>Helicobacter pylori</italic> c эпителием слизистой оболочки желудка. II. Реакция эпителия слизистой оболочки желудка в ответ на колонизацию и персистирование <italic>H. pylori</italic></trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Pozdeev</surname><given-names>O. K.</given-names></name><name xml:lang="ru"><surname>Поздеев</surname><given-names>О. К.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>PhD, MD (Medicine), Professor, Head of the Department of Microbiology</p><p><bold><italic>Contacts:</italic></bold><italic> Oskar K. Pozdeev, 420012, Russian Federation, Kazan, Butlerova str., 36, Kazan State Medical Academy</italic></p></bio><bio xml:lang="ru"><p><bold>Поздеев Оскар Кимович</bold>, доктор мендицинских наук, профессор, зав. кафедрой микробиологии </p><p><bold><italic>Адрес для переписки: </italic></bold><italic>Поздеев Оскар Кимович 420012, Россия, г. Казань, ул. Бутлерова, 36,</italic></p></bio><email>pozdeevoskar@rambler.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Pozdeeva</surname><given-names>A. O.</given-names></name><name xml:lang="ru"><surname>Поздеева</surname><given-names>А О</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Assistant of the Department of Therapy and Family Medicine</p></bio><bio xml:lang="ru"><p><bold>Поздеева Адель Оскаровна</bold>, ассистент кафедры терапии и семейной медицины</p></bio><email>pozdeevoskar@rambler.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Valeeva</surname><given-names>Yu. V.</given-names></name><name xml:lang="ru"><surname>Валеева</surname><given-names>Ю. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>PhD (Medicine), Associate Professor, Department of Emergency Medical Care and Simulatory Medicine</p></bio><bio xml:lang="ru"><p><bold>Валеева Юлия Владимировна</bold>, кандидат медицинских наук, доцент кафедры неотложной медицинской помощи и симуляционной медицины</p></bio><email>val_iulia@mail.ru</email><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Gulyaev</surname><given-names>P. E.</given-names></name><name xml:lang="ru"><surname>Гуляев</surname><given-names>П. Е.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Assistant of the Department of Microbiology</p></bio><bio xml:lang="ru"><p><bold>Гуляев Павел Евгеньевич</bold>, ассистент кафедры микробиологии �гии</p></bio><email>just-esteto@mail.ru</email><xref ref-type="aff" rid="aff3"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Savinova</surname><given-names>A. N.</given-names></name><name xml:lang="ru"><surname>Савинова</surname><given-names>А. Н.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>PhD (Biology), Associate Professor, Department of Microbiology</p></bio><bio xml:lang="ru"><p><bold>Савинова Альфия Николаевна</bold>, кандидат биологических наук, доцент кафедры микробиологии</p></bio><email>kazan-55@mail.ru</email><xref ref-type="aff" rid="aff3"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Kazan State Medical Academy — Branch Campus of the Russian Medical Academy of Continuous Professional Education</institution></aff><aff><institution xml:lang="ru">Казанская государственная медицинская академия — филиал ФГБОУ ДПО Российская медицинская академия непрерывного профессионального образования МЗ РФ</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">Kazan (Volga region) Federal University</institution></aff><aff><institution xml:lang="ru">ФГАОУ ВО Казанский (Приволжский) федеральный университет</institution></aff></aff-alternatives><aff-alternatives id="aff3"><aff><institution xml:lang="en">Kazan State Medical University</institution></aff><aff><institution xml:lang="ru">ФГБОУ ВО Казанский государственный медицинский университет МЗ РТ</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2019-07-12" publication-format="electronic"><day>12</day><month>07</month><year>2019</year></pub-date><volume>9</volume><issue>2</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>253</fpage><lpage>261</lpage><history><date date-type="received" iso-8601-date="2018-04-03"><day>03</day><month>04</month><year>2018</year></date><date date-type="accepted" iso-8601-date="2019-04-05"><day>05</day><month>04</month><year>2019</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2019, Pozdeev O.K., Pozdeeva A.O., Valeeva Y.V., Gulyaev P.E., Savinova A.N.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2019, Поздеев О.К., Поздеева А.О., Валеева Ю.В., Гуляев П.Е., Савинова А.Н.</copyright-statement><copyright-year>2019</copyright-year><copyright-holder xml:lang="en">Pozdeev O.K., Pozdeeva A.O., Valeeva Y.V., Gulyaev P.E., Savinova A.N.</copyright-holder><copyright-holder xml:lang="ru">Поздеев О.К., Поздеева А.О., Валеева Ю.В., Гуляев П.Е., Савинова А.Н.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://iimmun.ru/iimm/article/view/635">https://iimmun.ru/iimm/article/view/635</self-uri><abstract xml:lang="en"><p>Gastric and duodenal recurrent inflammatory diseases have a high prevalence, but the role played by microbes in its development remained unclear. However, the data published in 1983 by Marshall and Warren about isolating <italic>Helicobacter pylori</italic> from the stomach mucosa of the patient with gastritis and proposing relevant cultivation methods was the turning point in investigating etiology of the upper digestive tract inflammatory disorders. Moreover, it was shown that the majority of <italic>H. pylori</italic> spp. are found within the gastric lumen upon colonization, whereas around 20% of them are attached to the epithelial cells in the stomach. In addition, effects of interacting H. pylori with gastric epithelium and activation of some defense mechanisms due to bacterial colonization and spreading were analyzed. It was found that along with triggering pro-inflammatory response induced by proteins VacA as well as phosphorylated/unphosphorylated CagA, wherein the latter is able to induce a set of protective reactions <italic>H. pylori</italic> disrupts intercellular contacts, affects epithelial cell polarity and proliferation, and activates SHP-2 phosphatase resulting in emerging diverse types of cellular responses. The activation mechanisms for the mitogen-activated protein kinase (MAPK) pathway were discussed. The ability of <italic>H. pylori</italic> to regulate apoptosis, particularly via its suppression, by expressing ERK kinase and protein MCL1 facilitating bacterial survival in the gastric mucosa as well as beneficial effects related to bacterial circulation on gastric epithelial cell survival elicited by anti-apoptotic factors were also examined. Of note, persistence of H. pylori are mainly determined by activating transcriptional factors including NF-κB, NFAT, SRF, T-cell lymphoid enhancing factor (TCF/LEF), regulating activity of MCL1 protein, in turn, being one of the main anti-apoptotic factors, as well as induced production of the migration inhibitory factor (MIF). The role of VacA cytotoxin in triggering epithelial cell apoptosis via caspase-mediated pathways was also considered. Infection with <italic>H. pylori</italic> is accompanied by release of proinflammatory cytokine cocktail detected both <italic>in vitro</italic> and <italic>in vivo</italic>. In particular, bacterial urease activating transcriptional factor NF-κB was shown to play a crucial role in inducing cytokine production. Moreover, such signaling pathways may be activated after <italic>H. pylori</italic> is attached to the cognate receptor in the gastric epithelial surface by interacting with CD74 and MHC class II molecules. Finally, a role for various CD4<sup>+</sup> T cell subsets, particularly type 17 T helper cells (Th17) in inducing immune response against H. pylori antigens in gastric mucosa was revealed were also discussed. </p></abstract><trans-abstract xml:lang="ru"><p>Распространенность рецидивирующих воспалительных заболеваний желудка и двенадцатиперстной кишки велика, однако роль микробов в развитии данной патологии оставалась неясной. Переломный момент в изучении этиологии воспалительных заболеваний верхних отделов пищеварительного тракта произошел после опубликования B.J. Marshall и J.R. Warren (1983) результатов выделения <italic>Helicobacter pylori</italic> со слизистой оболочки желудка больного, страдающего гастритом, и методах культивирования этих бактерий. Большинство бактерий вида <italic>H. pylori</italic> при колонизации организма находятся в свободном состоянии, но около 20% присоединяется к эпителиальным клеткам желудка. Были проанализированы последствия взаимодействия H. pylori с эпителием слизистой оболочки желудка и активации защитных механизмов, вызванных колонизацией и циркуляцией бактерий. Показано, что наряду с запуском провоспалительного ответа, индуцированного белками VacA и CagA, в котором последний способен вызывать комплекс ответных реакций, как в фосфорилированной, так и в нефосфорилированной форме, <italic>H. pylori</italic> повреждает межклеточные контакты, нарушает полярность и пролиферацию эпителия, активирует фосфатазы SHP-2, что приводит к развитию различных клеточных ответов. Рассмотрены механизмы запуска митоген-активируемого протеинкиназного каскада (MAPK). Обсуждены способность <italic>H. pylori</italic> регулировать процесс апоптоза, а именно его подавления, через экспрессию киназы ERK и белка MCL1, что облегчает его выживание на слизистой желудка, а также позитивное влияние циркуляции бактерий на выживание эпителиоцитов посредством индукции антиапоптотических факторов в клетках эпителия желудка. В значительной мере такие процессы, как активация транскрипционных факторов (NF-κB, NFAT, SRF, T-клеточный лимфоидный энхансерный фактор [TCF/LEF]), регуляция активности белка MCL1, который в свою очередь является одним из основных антиапоптотических факторов, и индукция синтеза фактора торможения миграции (MIF) обусловливают персистенцию <italic>H. pylori</italic>. Рассмотрено участие цитотоксина VacA в индукции апоптоза эпителиоцитов посредством запуска каскадных реакций, осуществляемых каспазами. Инфицирование H<italic>. pylori </italic>сопровождается секрецией комплекса провоспалительных цитокинов, причем данные подтверждаются как <italic>in</italic> <italic>vitro</italic>, так и <italic>in vivo.</italic> Основную роль в выработке данных цитокинов играет уреаза, которая активирует транскрипционный фактор NF-κB. Кроме того, сигнальные системы эпителия желудка могут быть активированы в результате связывания бактерий с рецептором на поверхности эпителиоцитов (взаимодействие с CD74 и молекулами II класса главного комплекса гистосовместимости). Рассмотрено участие различных субпопуляций CD4<sup>+</sup> T-клеток, в частности Т-хелперов 17 (Th17), в формировании иммунного ответа к антигенам <italic>H. pylori</italic> в слизистой оболочке желудка. </p></trans-abstract><kwd-group xml:lang="en"><kwd>Helicobacter pylori</kwd><kwd>cytokines</kwd><kwd>gastric mucosal epitheliocytes</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>Helicobacter pylori</kwd><kwd>цитокины</kwd><kwd>эпителиоцыты слизистой оболочки желудка.</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>1. Поздеев О.К., Поздеева А.О., Валеева Ю.В., Гуляев П.Е. Механизмы взаимодействия Helicobacter pylori c эпителием слизистой оболочки желудка. I. Факторы патогенности, способствующие успешной колонизации // Инфекция и иммунитет. 2018. Т. 8, № 3. С. 273–283. doi: 10.15789/2220-7619-2018-3-273-283</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>2. Al-Daccak R., Mooney N., Charron D. MHC class II signaling in antigen-presenting cells. Curr. Opin. Immunol., 2004, vol. 16, no. 1, pp. 108–113. doi: 10.1016/j.coi.2003.11.006</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>3. Amieva M.R., El-Omar E.M. Host-bacterial interactions in Helicobacter pylori infection. Gastroenterology, 2008, vol. 134, no. 1, pp. 306–323. doi: 10.1053/j.gastro.2007.11.009</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>4. Amieva M.R., Vogelmann R., Covacci A., Tompkins L.S., Nelson W.J., Falkow S. Disruption of the epithelial apical-junctional complex by Helicobacter pylori CagA. Science, 2003, vol. 300, no. 5624, pp. 1430–1434. doi: 10.1126/science.1081919</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>5. Ashktorab H., Dashwood R.H., Dashwood M.M., Zaidi S.I., Hewitt S.M., Green W.R., Lee E.L., Daremipouran M., Nouraie M., Malekzadeh R., Smoot D.T. H. pylori-induced apoptosis in human gastric cancer cells mediated via the release of apoptosis-inducing factor from mitochondria. Helicobacter, 2008, vol. 13, no. 6, pp. 506–517. doi: 10.1111/j.1523-5378.2008.00646.x</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>6. Bagnoli F., Buti L., Tompkins L., Covacci A., Amieva M.R. Helicobacter pylori CagA induces a transition from polarized to invasive phenotypes in MDCK cells. Proc. Natl. Acad. Sci. USA, 2005, vol. 102, no. 45, pp. 16339–16344. doi: 10.1073/pnas.0502598102</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>7. Barrera C.A., Beswick E.J., Sierra J.C., Bland D., Espejo R., Mifflin R., Adegboyega P., Crowe S.E., Ernst P.B. Polarized expression of CD74 by gastric epithelial cells. J. Histochem. Cytochem., 2005, vol. 53, no. 12, pp. 1481–1489. doi: 10.1369/jhc.4A6552.2005</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>8. Beswick E.J., Bland D.A., Suarez G., Barrera C.A., Fan X.J., Reyes V.E. Helicobacter pylori binds to CD74 on gastric epithelial cells and stimulates interleukin-8 production. Infect. Immun., 2005, vol. 73, no. 5, pp. 2736–2743. doi: 10.1128/IAI.73.5.27362743.2005</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>9. Beswick E.J., Pinchuk I.V., Minch K., Suarez G., Sierra J.C., Yamaoka Y., Reyes V.E. The Helicobacter pylori urease B subunit binds to CD74 on gastric epithelial cells and induces NF-kappaB activation and interleukin-8 production. Infect. Immun., 2006, vol. 74, no. 2, pp. 1148–1155. doi: 10.1128/IAI.74.2.1148-1155.2006</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>10. Beswick E.J., Pinchuk I.V., Suarez G., Sierra J.C., Reyes V.E. Helicobacter pylori CagA-dependent macrophage migration inhibitory factor produced by gastric epithelial cells binds to CD74 and stimulates procarcinogenic events. J. Immunol., 2006, vol. 176, no. 11, pp. 6794–6801. doi: 10.4049/jimmunol.176.11.6794</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>11. Chang Y.J., Wu M.S., Lin J.T., Pestell R.G., Blaser M.J., Chen C.C. Mechanisms for Helicobacter pylori CagA-induced cyclin D1 expression that affect cell cycle. Cell. Microbiol., 2006, vol. 8, no. 11, pp. 1740–1752. doi: 10.1111/j.1462-5822.2006.00743.x</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>12. Churin Y., Al-Ghoul L., Kepp O., Meyer T.E., Birchmeier W., Naumann M. Helicobacter pylori CagA protein targets the c-Met receptor and enhances the motogenic response. J. Cell. Biol., 2003, vol. 161, no. 2, pp. 249–255. doi: 10.1083/jcb.200208039</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>13. Crabtree J.E., Farmery S.M., Lindley I.J., Figura N., Peichl P., Tompkins D.S. CagA/cytotoxic strains of Helicobacter pylori and interleukin-8 in gastric epithelial cell lines. J. Clin. Pathol., 1994, vol. 47, no. 10, pp. 945–950. doi: 10.1136/jcp.47.10.945</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>14. Crabtree J.E., Naumann M. Epithelial cell signaling in Helicobacter pylori infection. Curr. Signal Transd., 2006, vol. 1, no. 1, pp. 53–65. doi: 10.2174/157436206775269253</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>15. Crabtree J.E., Shallcross T.M., Heatley R.V., Wyatt J.I. Mucosal tumour necrosis factor alpha and interleukin-6 in patients with Helicobacter pylori associated gastritis. Gut, 1991, vol. 32 , no. 12, pp. 1473–1477. doi: 10.1136/gut.32.12.1473</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>16. Crabtree J.E., Wyatt J.I., Trejdosiewicz L.K., Peichl P., Nichols P.H., Ramsay N., Primrose J.N., Lindley I.J.D. Interleukin-8 expression in Helicobacter pylori infected, normal, and neoplastic gastroduodenal mucosa. J. Clin. Pathol., 1994, vol. 47, no. 1, pp. 61–66. doi: 10.1136/jcp.47.1.61</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>17. De Guzman B.B., Hisatsune J., Nakayama M., Yahiro K., Wada A., Yamasaki E., Nishi Y., Yamazaki S., Azuma T., Ito Y., Ohtani M., van der Wijk T., den Hertog J., Moss J., Hirayama T. Cytotoxicity and recognition of receptor-like protein tyrosine phosphatases, RPTPalpha and RPTPbeta, by Helicobacter pylori m2VacA. Cell. Microbiol., 2005, vol. 7, no. 9, pp. 1285–1293. doi: 10.1111/j.1462-5822.2005.00556.x</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>18. Fan X., Crowe S.E., Behar S., Gunasena H., Ye G., Haeberle H., Van Houten N., Gourley W.K., Ernst P.B., Reyes V.E. The effect of class II major histocompatibility complex expression on adherence of Helicobacter pylori and induction of apoptosis in gastric epithelial cells: a mechanism for T helper cell type 1-mediated damage. J. Exp. Med., 1998, vol. 187, no. 10, pp. 1659–1669. doi: 10.1084/jem.187.10.1659</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>19. Fan X., Gunasena H., Cheng Z., Espejo R., Crowe S.E., Ernst P.B., Reyes V.E. Helicobacter pylori urease binds to class II MHC on gastric epithelial cells and induces their apoptosis. J. Immunol., 2000, vol. 165, no. 4, pp. 1918–1924. doi: 10.4049/jimmunol.165.4.1918</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>20. Fischer W., Prassl S., Haas R. Virulence mechanisms and persistence strategies of the human gastric pathogen Helicobacter pylori. Curr. Top. Microbiol. Immunol., 2009, vol. 337, pp. 129–171. doi: 10.1007/978-3-642-01846-6_5</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>21. Higashi H., Tsutsumi R., Muto S., Sugiyama T., Azuma T., Asaka M., Hatakeyama M. SHP-2 tyrosine phosphatase as an intracellular target of Helicobacter pylori CagA protein. Science, 2002, vol. 295, no. 5555, pp. 683–686. doi: 10.1126/science.1067147.</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>22. Ishiguro Y., Ohkawara T., Sakuraba H., Yamagata K., Hiraga H., Yamaguchi S., Fukuda S., Munakata A., Nakane A., Nishihira J. Macrophage migration inhibitory factor has a proinflammatory activity via the p38 pathway in glucocorticoid-resistant ulcerative colitis. Clin. Immunol., 2006, vol. 120, no. 3, pp. 335–341. doi: 10.1016/j.clim.2006.05.010</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>23. Iwai H., Kim M., Yoshikawa Y., Ashida H., Ogawa M., Fujita Y., Muller D., Kirikae T., Jackson P.K., Kotani S., Sasakawa C. A bacterial effector targets Mad2L2, an APC inhibitor, to modulate host cell cycling. Cell, 2007, vol. 130, no. 4, pp. 611–623. doi: 10.1016/j.cell.2007.06.043</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>24. Jung H.C., Kim J.M., Song I.S., Kim C.Y. Helicobacter pylori induces an array of pro-inflammatory cytokines in human gastric epithelial cells: quantification of mRNA for interleukin-8, -1 alpha/beta, granulocyte-macrophage colony-stimulating factor, monocyte chemoattractant protein-1 and tumour necrosis factor-alpha. J. Gastroenterol. Hepatol., 1997, vol. 12, no. 7, pp. 473– 480. doi: 10.1111/j.1440-1746.1997.tb00469.x</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>25. Kabir S. The role of interleukin-17 in the Helicobacter pylori induced infection and immunity. Helicobacter, 2011, vol. 16, no. 1, pp. 1–8. doi: 10.1111/j.1523-5378.2010.00812.x</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>26. Keates S., Keates A.C., Warny M., Peek R.M. Jr, Murray P.G., Kelly C.P. Differential activation on of mitogen-activated protein kinases in AGS gastric ati epithelial cells by cag+ and cag– Helicobacter pylori. J. Immunol., 1999, vol. 163, no. 10, pp. 5552–5559.</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>27. Lu H., Murata-Kamiya N., Saito Y., Hatakeyama M. Role of partitioning-defective 1/microtubule affinity-regulating kinases in the morphogenetic activity of Helicobacter pylori CagA. J. Biol. Chem., 2009, vol. 284, no. 34, pp. 23024–23036. doi: 10.1074/jbc.M109.001008</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>28. Lu H., Wu J.Y., Kudo T., Ohno T., Graham D.Y., Yamaoka Y. Regulation of interleukin-6 promoter activation in gastric epithelial cells infected with Helicobacter pylori. Mol. Biol. Cell, 2005, vol. 16, no. 10, pp. 4954–4966. doi: 10.1091/mbc.E05-05-0426</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>29. Matsushima K., Shiroo M., Kung H.F., Copeland T.D. Purification and characterization of a cytosolic 65-kilodalton phosphoprotein in human leukocytes whose phosphorylation is augmented by stimulation with interleukin 1. Biochemistry, 1988, vol. 27, no. 10, pp. 3765–3770. doi: 10.1021/bi00410a037</mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation>30. Mimuro H., Suzuki T., Nagai S., Rieder G., Suzuki M., Nagai T., Fujita Y., Nagamatsu K., Ishijima N., Koyasu S., Haas R., Sasakawa C. Helicobacter pylori dampens gut epithelial self-renewal by inhibiting apoptosis, a bacterial strategy to enhance colonization of the stomach. Cell Host Microbe, 2007, vol. 2, no. 4, pp. 250–263. doi: 10.1016/j.chom.2007.09.005</mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation>31. Mimuro H., Suzuki T., Tanaka J., Asahi M., Haas R., Sasakawa C. Grb2 is a key mediator of helicobacter pylori CagA protein activities. Mol. Cell, 2002, vol. 10, no. 4, pp. 745–755. doi: 10.1016/S1097-2765(02)00681-0</mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation>32. Mitchell R.A., Liao H., Chesney J., Fingerle-Rowson G., Baugh J., David J., Bucala R. Macrophage migration inhibitory factor (MIF) sustains macrophage proinflammatory function by inhibiting p53: regulatory role in the innate immune response. Proc Natl. Acad. Sci. USA, 2002, vol. 99, no. 1, pp. 345–350. doi: 10.1073/pnas.012511599</mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation>33. Mizuno T., Ando T., Nobata K., Tsuzuki T., Maeda O., Watanabe O., Minami M., Ina K., Kusugami K., Peek R.M., Goto H. Interleukin-17 levels in Helicobacter pylori-infected gastric mucosa and pathologic sequelae of colonization. World J. Gastroenterol., 2005, vol. 11, no. 40, pp. 6305–6311. doi: 10.3748/wjg.v11.i40.6305</mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation>34. Murata-Kamiya N., Kurashima Y., Teishikata Y., Yamahashi Y., Saito Y., Higashi H., Aburatani H., Akiyama T., Peek R.M., Azuma T., Hatakeyama M. Helicobacter pylori CagA interacts with E-cadherin and deregulates the beta-catenin signal that promotes intestinal transdifferentiation in gastric epithelial cells. Oncogene, 2007, vol. 26, no. 32, pp. 4617–4626. doi: 10.1038/sj.onc.1210251</mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation>35. Odenbreit S., Kavermann H., Püls J., Haas R. CagA tyrosine phosphorylation and interleukin-8 induction by Helicobacter pylori are independent from alpAB, HopZ and bab group outer membrane proteins. Int. J. Med. Microbiol., 2002, vol. 292, no. 3–4, pp. 257–266. doi: 10.1078/1438-4221-00205</mixed-citation></ref><ref id="B36"><label>36.</label><mixed-citation>36. Olivares D., Gisbert J.P., Pajares J.M. Helicobacter pylori infection and gastric mucosal epithelial cell apoptosis. Rev. Esp. Enferm. Dig., 2005, vol. 97, no. 7, pp. 505–520.</mixed-citation></ref><ref id="B37"><label>37.</label><mixed-citation>37. Oppenheim J.J., Zachariae C.O., Mukaida N., Matsushima K. Properties of the novel proinflammatory supergene “intercrine” cytokine family. Annu. Rev. Immunol., 1991, vol. 9, pp. 617–648. doi: 10.1146/annurev.iy.09.040191.003153</mixed-citation></ref><ref id="B38"><label>38.</label><mixed-citation>38. Parsons J.T. Focal adhesion kinase: the first ten years. J. Cell. Science, 2003, vol. 116, no. 8, pp. 1409–1416. doi: 10.1242/jcs.00373</mixed-citation></ref><ref id="B39"><label>39.</label><mixed-citation>39. Pinchuk I.V., Morris K.T., Nofchissey R.A., Earley R.B., Wu J.Y., Ma T.Y., Beswick E.J. Stromal cells induce Th17 during Helicobacter pylori infection and in the gastric tumor microenvironment. PLoS One, 2013, vol. 8, no. 1, pp. e53798. doi: 10.1371/journal.pone.0053798</mixed-citation></ref><ref id="B40"><label>40.</label><mixed-citation>40. Saadat I., Higashi H., Obuse C., Umeda M., Murata-Kamiya N., Saito Y., Lu H.S., Ohnishi N., Azuma T., Suzuki A., Ohno S., Hatakeyama M. Helicobacter pylori CagA targets PAR1/MARK kinase to disrupt epithelial cell polarity. Nature, 2007, vol. 447, no. 7142, pp. 330–333. doi: 10.1038/nature05765</mixed-citation></ref><ref id="B41"><label>41.</label><mixed-citation>41. Saberi S., Douraghi M., Azadmanesh K., Shokrgozar M.A., Zeraati H., Hosseini M.E., Mohagheghi M.A., Parsaeian M., Mohammadi M. A potential association between Helicobacter pylori CagA EPIYA and multimerization motifs with cytokeratin 18 cleavage rate during early apoptosis. Helicobacter, 2012, vol. 17, no. 5, pp. 350–357. doi: 10.1111/j.1523-5378.2012.00954.x</mixed-citation></ref><ref id="B42"><label>42.</label><mixed-citation>42. Sebkova L., Pellicanò A., Monteleone G., Grazioli B., Guarnieri G., Imeneo M., Pallone F., Luzza F. Extracellular signal-regulated protein kinase mediates interleukin 17 (IL-17)-induced IL-8 secretion in Helicobacter pylori-infected human gastric epithelial cells. Infect. Immun., 2004, vol. 72, no. 9, pp. 5019–5026. doi: 10.1128/IAI.72.9.5019-5026.2004</mixed-citation></ref><ref id="B43"><label>43.</label><mixed-citation>43. Shi Y., Liu X.F., Zhuang Y., Zhang J.Y., Liu T., Yin Z., Wu C., Mao X.H., Jia K.R., Wang F.J., Guo H., Flavell R.A., Zhao Z., Liu K.Y., Xiao B., Guo Y., Zhang W.J., Zhou W.Y., Guo G., Zou Q.M. Helicobacter pylori-induced Th17 responses modulate Th1 cell responses, benefit bacterial growth, and contribute to pathology in mice. J. Immunol., 2010, vol. 184, no. 9, pp. 5121–5129. doi: 10.4049/jimmunol.0901115</mixed-citation></ref><ref id="B44"><label>44.</label><mixed-citation>44. Tan S., Tompkins L.S., Amieva M.R. Helicobacter pylori usurps cell polarity to turn the cell surface into a replicative niche. PLoS Pathog., 2009, vol. 5, no. 5: e1000407. doi: 10.1371/journal.ppat.1000407</mixed-citation></ref><ref id="B45"><label>45.</label><mixed-citation>45. Tanahashi T., Kita M., Kodama T., Yamaoka Y., Sawai N., Ohno T., Mitsufuji S., Wei Y.P., Kashima K., Imanishi J. Cytokine expression and production by purified Helicobacter pylori urease in human gastric epithelial cells. Infect. Immun., 2000, vol. 68, no. 2, pp. 664–671. doi: 10.1128/IAI.68.2.664-671.2000</mixed-citation></ref><ref id="B46"><label>46.</label><mixed-citation>46. Wessler S., Backert S. Molecular mechanisms of epithelial-barrier disruption by Helicobacter pylori. Trends Microbiol., 2008, vol. 16, no. 8, pp. 397–405. doi: 10.1016/j.tim.2008.05.005</mixed-citation></ref><ref id="B47"><label>47.</label><mixed-citation>47. Wessler S., Höcker M., Fischer W., Wang T.C., Rosewicz S., Haas R., Wiedenmann B., Meyer T.F., Naumann M. Helicobacter pylori activates the histidine decarboxylase promoter through a mitogen-activated protein kinase pathway independent of pathogenicity island-encoded virulence factors. J. Biol. Chem., 2000, vol. 275, no. 5, pp. 3629–3636. doi: 10.1074/jbc.275.5.3629</mixed-citation></ref><ref id="B48"><label>48.</label><mixed-citation>48. Xia H.H., Talley N.J. Apoptosis in gastric epithelium induced by Helicobacter pylori infection: implications in gastric carcinogenesis. Am. J. Gastroenterol., 2001, vol. 96, no. 1, pp. 16–26. doi: 10.1016/S0002-9270(00)02240-1</mixed-citation></ref><ref id="B49"><label>49.</label><mixed-citation>49. Xia Z., Dickens M., Raingeaud J., Davis R.J., Greenberg M.E. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science, 1995, vol. 270, no. 5240, pp. 1326–1331. doi: 10.1126/science.270.5240.1326</mixed-citation></ref><ref id="B50"><label>50.</label><mixed-citation>50. Xiong S., Mu T., Wang G., Jiang X. Mitochondria-mediated apoptosis in mammals. Protein Cell., 2014, vol. 5, no. 10, pp. 737–749. doi: 10.1007/s13238-014-0089-1</mixed-citation></ref><ref id="B51"><label>51.</label><mixed-citation>51. Yokoyama K., Higashi H., Ishikawa S., Fujii Y., Kondo S., Kato H., Azuma T., Wada A., Hirayama T., Aburatani H., Hatakeyama M. Functional antagonism between Helicobacter pylori CagA and vacuolating toxin VacA in control of the NFAT signaling pathway in gastric epithelial cells. Proc. Natl. Acad. Sci. USA, 2005, vol. 102, no. 27, pp. 9661–9666. doi: 10.1073/pnas.0502529102</mixed-citation></ref></ref-list></back></article>
